Biology subjects

Suwa, Y.

Publications and source records attributed to Suwa, Y..

3 recordsLinked to original sources

bioRxiv2025

Structural Basis of Herpesvirus Helicase-Primase Inhibition by Pritelivir and Amenamevir

Widespread herpesvirus infections are associated with various diseases. DNA replication of human herpes simplex virus type 1 (HSV-1) requires a helicase-primase (HP) complex of three core proteins: UL5, UL52, and UL8. This complex unwinds viral DNA and synthesizes primers for DNA replication, making it an attractive antiviral target. Although HP inhibitors pritelivir and amenamevir were identified through screening, their binding mechanisms remain unclear. Here, we report cryo-EM structures of HSV-1 HP bound to a forked DNA template alone, and in complex with pritelivir or amenamevir. The structures reveal a bilobed architecture highlighting helicase-primase coordinated action at the replication fork and providing a structural basis for HP inhibition by illustrating precisely how pritelivir and amenamevir block helicase activity. Data lays a solid foundation for the development of improved antiviral therapies.

biochemistry↗

bioRxiv2023

A method for evaluating hunger and thirst in monkeys by measuring blood ghrelin and osmolality levels

Hunger and thirst drive animals consumption behavior and regulate their decision-making regarding rewards. We previously assessed the thirst states of monkeys by measuring blood osmolality under controlled water access and related the thirst states to risky decisions for fluid rewards. However, hunger assessments in monkeys have been poorly performed. Moreover, the lack of precise measures for hunger states leads to another issue regarding how hunger and thirst states interact with each other in each individual. Thus, when controlling food access to motivate subject performances, how these two physiological needs are satisfied in captive monkeys remains unclear. Here, we measured blood ghrelin levels and osmolality for hunger and thirst, respectively, in four captive macaques. Using enzyme-linked immunosorbent assay, we found that the levels of blood ghrelin, a widely measured hunger-related peptide hormone in humans, were high after 20 h of no food access (with ad libitum water), which is a typical controlled food access condition. One hour after consuming the regular dry meal, the value decreased in three out of four monkeys to within the range of individual blood ghrelin levels. Additionally, blood osmolality measured from the same blood sample, the standard hematological index of hydration status, increased after consuming regular dry meals with no water access. Thus, ghrelin and osmolality may provide a precise reflection of the physiological states of individual monkeys for hunger and thirst, suggesting that these indices can be used as a tool for monitoring hunger and thirst levels that mediate the animals decision-making for consuming rewards.

neuroscience↗

bioRxiv2020

Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides

IF7 peptide, which binds to the annexin A1 (ANXA1) N-terminal domain, functions as a tumor vasculature-targeted drug delivery vehicle after intravenous injection. To enhance IF7 stability in vivo, we undertook mirror-image peptide phage display using a synthetic D-peptide representing the Anxa1 N-terminus as target. Peptide sequences were identified, synthesized as D-amino acids, and designated as dTIT7, which was shown to bind the ANXA1 N-terminus. Whole body imaging of mouse brain tumors modeled with near infrared fluorescent IRDye-conjugated dTIT7 showed fluorescent signals in brain and kidney. Furthermore, orally-administered geldanamycin (GA)-conjugated dTIT7 suppressed brain tumor growth. Ours is a proof-of-concept experiment showing that Anxa1-binding D-peptide could be developed as an orally-administrable, tumor vasculature-targeted therapeutic. Role of each author: MN designed and performed experiments, analyzed data, and wrote the manuscript; HMA and DLJ produced recombinant ANXA1 protein; KY conducted NMR analysis and data analysis; TOA designed, performed and analyzed LC-MS/MS data; MN, TS, IKT, YS, and TY analyzed peptide-binding assays and performed in silico structural analysis; CTU produced lentivirus for luciferase expression; CNH performed peptide binding assays, tissue culture and animal experiments; and MNF supervised the project and wrote the manuscript.

pharmacology and toxicology↗